It has been demonstrated that prolonged graft survival can be achieved through inhibiting the activation of T cells, and addition of soluble CTLA4Ig and OX40Ig
Fibroblast is a crucial kind of cell in the construction of the tissue engineered dermal equivalent. In order to optimize the cryopreservation protocols of the